首页 | 本学科首页   官方微博 | 高级检索  
     

多西他赛联合奥沙利铂在晚期食管癌治疗中的临床研究
引用本文:王强,张克,张灿斌,王红岩. 多西他赛联合奥沙利铂在晚期食管癌治疗中的临床研究[J]. 现代预防医学, 2011, 38(16): 3377-3378,3380
作者姓名:王强  张克  张灿斌  王红岩
作者单位:河南科技大学第一附属医院胸外科,洛阳,471003
摘    要:[目的]探讨多西他赛联合奥沙利铂治疗晚期食管癌的疗效及不良反应。[方法]经影像及病理组织学确诊的65例晚期食管癌患者,采用多西他赛联合奥沙利铂联合方案进行化疗,多西他赛75mg/m2静脉滴注90min,d1;奥沙利铂135mg/m2静脉滴注3h,d2,21d为1个周期,每2疗程评价疗效。[结果]65例患者完全缓解(CR)0例,部分缓解(PR)31例(47.69%),总有效率(CR+PR)47.69%,疾病进展时间:3.5~8.5个月,中位生存期4.8~25个月。在疼痛缓解、全身情况明显改善,生存质量和KPS评分提高等方面均取得了较好疗效。主要不良反应为骨髓抑制、外周神经毒性、消化道反应等。无治疗相关死亡者。[结论]多西他赛联合奥沙利铂治疗晚期食管癌安全、有效率高,毒性反应可以耐受。

关 键 词:多西他赛  奥沙利铂  食管癌  化疗

CLINICAL STUDY OF DOXETAXEL COMBINED WITH OXALIPLATIN IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER
WANG Qiang,ZHANG Ke,ZHANG Can-bin,et al.. CLINICAL STUDY OF DOXETAXEL COMBINED WITH OXALIPLATIN IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER[J]. Modern Preventive Medicine, 2011, 38(16): 3377-3378,3380
Authors:WANG Qiang  ZHANG Ke  ZHANG Can-bin  et al.
Affiliation:WANG Qiang,ZHANG Ke,ZHANG Can-bin,et al.(Department of Thoracic,the First Affiliated Hospital of Henan Technology University,Luoyang 471003,China)
Abstract:[Objective]To evaluate the efficiency and toxicity of combination chemotherapy with doxetaxel and oxaliplatin in treatment of the patients of advanced esophageal cancer.[Methods]65 advanced esophageal cancer confirmed by maging and pathday finding were enrolled in this study. The regimen:TXT 75mg/m2 iv 90min,d1;L-OHP 135mg/m2 iv 3h,d2;and every 21 days as one cycle. After two consecutive treatment courses,the evaluation of the short term efficacy and adverse effects was carried out.[Results]65 patients were...
Keywords:Doxetaxel  Oxaliplatin  Esophageal neoplasm  Chemotherapy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号